Abstract
The enzymatic pathways leading to the synthesis of bioactive steroids in the brain are now almost completely elucidated in various groups of vertebrates and, during the last decade, the neuronal mechanisms involved in the regulation of neurosteroid production have received increasing attention. This report reviews the current knowledge concerning the effects of neurotransmitters, peptide hormones, and neuropeptides on the biosynthesis of neurosteroids. Anatomical studies have been carried out to visualize the neurotransmitter- or neuropeptide-containing fibers contacting steroid-synthesizing neurons as well as the neurotransmitter, peptide hormones, or neuropeptide receptors expressed in these neurons. Biochemical experiments have been conducted to investigate the effects of neurotransmitters, peptide hormones, or neuropeptides on neurosteroid biosynthesis, and to characterize the type of receptors involved. Thus, it has been found that glutamate, acting through kainate and/or AMPA receptors, rapidly inactivates P450arom, and that melatonin produced by the pineal gland and eye inhibits the biosynthesis of 7α-hydroxypregnenolone (7α-OH-Δ5P), while prolactin produced by the adenohypophysis enhances the formation of 7α-OH-Δ5P. It has also been demonstrated that the biosynthesis of neurosteroids is inhibited by GABA, acting through GABAA receptors, and neuropeptide Y, acting through Y1 receptors. In contrast, it has been shown that the octadecaneuropetide ODN, acting through central-type benzodiazepine receptors, the triakontatetraneuropeptide TTN, acting though peripheral-type benzodiazepine receptors, and vasotocin, acting through V1a-like receptors, stimulate the production of neurosteroids. Since neurosteroids are implicated in the control of various neurophysiological and behavioral processes, these data suggest that some of the neurophysiological effects exerted by neurotransmitters and neuropeptides may be mediated via the regulation of neurosteroid production.
Introduction
The regulatory effects of steroid hormones in the central nervous system (CNS) have long been recognized (McEwen, 1994; Baulieu et al., ; Dubrovsky, ; Leskiewicz et al., 2006). Steroids acting on the CNS originate from two sources: (1) steroids produced by peripheral endocrine glands, i.e., gonads, adrenal, and placenta, that have to cross the blood–brain barrier to act on the brain, are usually designated as neuroactive steroids; (2) steroids directly synthesized within the CNS, either de novo from cholesterol or by in situ metabolism of circulating steroid precursors, are designated by the generic term neurosteroids (Robel and Baulieu, 1985, 1994; Baulieu, , ). The capability of the nervous system to synthesize steroids was originally discovered in mammals (Corpéchot et al., , ; Lanthier and Patwardhan, 1986) and was subsequently generalized in other vertebrates including birds, amphibians, and fish (Mensah-Nyagan et al., 1999; Mellon and Vaudry, 2001; Tsutsui et al., 2003, 2009; Do Rego et al., ; Diotel et al., ) indicating that de novo neurosteroidogenesis is a conserved property in the vertebrate phylum.
There is growing evidence that neurosteroids play an important role as endogenous modulators of neuronal functions and behavioral processes, and that alterations of neurosteroid concentrations may contribute to the pathophysiology of neuronal disorders (Majewska, 1992; Robel et al., 1999; Rupprecht and Holsboer, 1999; Lapchak et al., 2000; Lapchak and Araujo, 2001; Rupprecht et al., 2001; Dubrovsky, ; Belelli et al., ; Strous et al., 2006). For instance, in rat, infusion of pregnenolone sulfate (Δ5PS) and dehydroepiandrosterone sulfate (DHEAS) into the nucleus basalis magnocellularis enhances learning and memory (Mayo et al., 1993; Robel et al., 1995). Reciprocally, deficit in cognitive performances in aged rats and mice is correlated with low Δ5PS and DHEAS levels in the hippocampus (Flood et al., 1988, 1992; Vallée et al., 1997, 2001; Ladurelle et al., 2000). In chickens, administration of DHEA and DHEAS enhances learning and memory (Migues et al., 2002). In humans, DHEA and DHEAS are considered to play a role in memory both in normal subjects and aging patients (Sunderland et al., 1989; Nasman et al., 1991; Strous et al., 2006). More specifically, with regards to Alzheimer’s disease, decreased levels of several neurosteroids have been observed in the frontal cortex, hippocampus, amygdala, striatum, hypothalamus, and cerebellum (Sunderland et al., 1989; Nasman et al., 1991; Weill-Engerer et al., 2002; Schumacher et al., 2003). The best known role of neurosteroids is their involvement in the control of mood disorders. Numerous behavioral investigations have shown that neurosteroids exert anxiolytic (Hodge et al., 2002; Strous et al., 2003), anti-depressant (Uzunova et al., 2003; van Broekhoven and Verkes, 2003), anti-aggressive (Kavaliers and Kinsella, 1995; Pinna et al., 2008), hypnotic (Lancel et al., 1997; Damianisch et al., ), anti-convulsive (Landgren et al., 1987; Belelli et al., ), and anti-stress actions (Patchev et al., 1996; Hu et al., 2000). In animal models, an effect of neurosteroids in eating disorders has been reported (Reddy and Kulkarni, 1998, 1999; Strous et al., 2006). In particular, DHEA decreases food intake (Svec and Porter, 1996; Svec et al., 1998), reduces insulin resistance (Svec and Porter, 1998a,b), and lowers adiposity (Svec and Porter, 1998a,b; Pham et al., 2000). DHEAS has also been found to induce a significant decrease in food intake and body weight (Reddy and Kulkarni, 1999; Kaur and Kulkarni, 2001). In contrast, allopregnanolone causes hyperphagia in male and female rats (Reddy and Kulkarni, 1999). The dose-dependent effects of Δ5PS on locomotion of mice placed in a novel environment show the existence of a possible role of neurosteroids in adaptation to novelty (Fahey et al., ). Neurosteroids are also involved in the regulation of excitotoxic and apoptotic processes (Kimonides et al., 1999; Frank and Sagratella, 2000; Manji et al., 2003; Charalampopoulos et al., ; Wojtal et al., 2006). In vivo studies indicate that progesterone, allopregnanolone, and DHEA exert neuroprotective effects in models of traumatic brain injury (Stein, 2001; Malik et al., 2003; Djebaili et al., ; He et al., 2004) and in focal cerebral ischemia (Malik et al., 2003; Sayeed et al., 2006). In vitro data also point to the neuroprotective effects of neurosteroids in models of neuronal injury against neurotoxic insults inflicted by excitatory amino acids (Kimonides et al., 1999; Gursoy et al., 2001) and β-amyloid peptides (Kimonides et al., 1998, 1999; Frank and Sagratella, 2000; Lockhart et al., 2002; Xilouri and Papazafiri, 2006). It has been demonstrated that neurosteroids play important functions in neurodevelopment and neuronal remodeling, including neurogenesis (Roberts, 1986; Weaver et al., 1997; Schumacher et al., 2000; Magnaghi et al., 2001; Young, 2002), axonal and dendritic growth, and synaptic connectivity (Jones, 1994; Compagnone and Mellon, ). In addition to their protective effects on the brain, neurosteroids can regulate myelin formation and increase expression of myelin proteins in the sciatic nerve (Koenig et al., 1995; Murakami et al., 2000; Plassart-Schiess and Baulieu, 2001; Laurine et al., 2003; Melcangi et al., 2003; Iwata et al., 2005).
The effects of neurosteroids on neuronal activity are mediated through several distinct categories of receptors. Neurosteroids, like other steroid hormones, can act at the transcriptional level through interaction with nuclear receptors (McEwen, 1994; Rupprecht, 1997; Mo et al., 2004). Neurosteroids may also interact with plasma membrane G protein-coupled receptors either directly (Schiess and Partridge, 2005; Tasker et al., 2006) or indirectly by modulating the binding of neuropeptides to their receptors (Grazzini et al., 1998; Zwain et al., 2002; Torres and Ortega, 2003). In addition, neurosteroids can stimulate tubulin polymerization in cultured neurons by binding to the microtubule-associated protein-2 (Murakami et al., 2000; Plassart-Schiess and Baulieu, 2001; Laurine et al., 2003; Iwata et al., 2005). However, most of the actions of neurosteroids are mediated via allosteric modulation of neurotransmitter receptors, including the GABAA/central-type benzodiazepine receptor (CBR) complex (Belelli and Lambert, ; Belelli et al., ; Zheng, 2009), N-methyl-d-aspartate (NMDA; Mameli et al., 2005; Monnet and Maurice, 2006), kainate (Costa et al., ; Dubrovsky, ), α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA; Rupprecht and Holsboer, 2001; Dubrovsky, ), glycine (Jiang et al., 2006; Mitchell et al., 2007), sigma (Monnet et al., 1995; Maurice et al., 2006), serotonergic (Kostowski and Bienkowski, 1999; Shannon et al., 2005a,b), nicotinic (Valera et al., 1992; Bullock et al., ), and muscarinic receptors (Horishita et al., 2005; Steffensen et al., 2006). For example, the effects of GABA on the GABAA receptor are allosterically potentiated by progesterone and deoxycorticosterone metabolites such as allopregnanolone, pregnanolone, and tetrahydrodeoxycorticosterone (Majewska et al., 1986; Majewska, 1992; Paul and Purdy, 1992; Bergeron et al., ). On the other hand, Δ5PS and DHEA have been reported to inhibit GABAA receptor activity (Majewska and Schwartz, 1987; Park-Chung et al., 1999). Allopregnanolone is a negative modulator of the NMDA receptors (Wu et al., 1991; Bowlby, ). In contrast, Δ5PS and DHEA potentiate several NMDA-receptor-mediated responses, and thus act as excitatory neurosteroids (Wu et al., 1991; Irwin et al., 1992; Fahey et al., ; Compagnone and Mellon, ). At the AMPA and kainate receptors, Δ5PS behaves as a negative modulator (Rupprecht, 1997; Mellon and Griffin, 2002). It has also been demonstrated that DHEAS acts as a sigma receptor agonist, Δ5PS as a sigma receptor inverse agonist, and progesterone as a sigma receptor antagonist (Monnet et al., 1995).
The biochemical pathways leading to the synthesis of steroids in the nervous system of vertebrates have now been almost completely elucidated (Tsutsui and Yamazaki, 1995; Tsutsui et al., 1999; Compagnone and Mellon, ; Do Rego et al., ; Diotel et al., ; Vaudry et al., 2011) and it is now firmly established that neurosteroids regulate neuronal activity (Reddy, 2003, 2010; Dubrovsky, ; Belelli et al., ; Strous et al., 2006). Over the last decade, a number of studies have thus been undertaken to decipher the neuronal mechanisms involved in the regulation of neurosteroid production. In the present report, we review the current knowledge regarding the effects and mode of action of neurotransmitters, peptide hormones, and neuropeptides on the biosynthesis of neurosteroids in the CNS of vertebrates. Remarkably, most of these studies have been conducted in the brain of amphibians and birds. In fact, since the rate of steroid synthesis is relatively high in the CNS of frog, quail, and zebra finch (Mensah-Nyagan et al., 1994, 1996; Tsutsui et al., 2006, 2009; Do Rego et al., ; Schlinger and Remage-Healey, 2011), these animals have proved to be suitable models in which to investigate the neuronal mechanisms regulating neurosteroid production.
Effect of Glutamate on Neurosteroid Biosynthesis
In the quail forebrain, all classes of ionotropic glutamate receptors, i.e., NMDA, AMPA, and kainate receptors, are expressed in the medial preoptic nucleus, a region which is enriched with P450arom-containing cell bodies (Cornil et al., ), suggesting that these neurons may be regulated by glutamate. Consistent with this hypothesis, incubation of quail hypothalamic fragments with AMPA and kainate, and to a certain extent NMDA, inhibits P450arom activity (Balthazart et al., ). In mice, administration of NMDA or glutamate within the nidopallium provokes a substantial decrease in the local concentration of estradiol (Remage-Healey et al., 2008; Cornil, ). These observations indicate that, in birds and mammals, glutamate exerts an inhibitory action on the formation of neuroestrogens. In the quail brain, the inhibitory effects of AMPA and kainate are mimicked by ATP, Ca2+ and Mg2+, and the Ca2+ response is abrogated by PKA, PKC, and CAMK (Balthazart et al., , ). Since P450arom possesses several concensus phosphorylation sites in its sequence (Harada, 1988; Balthazart et al., ), it appears that the rapid inhibitory effect of AMPA, kainate, or NMDA on P450arom activity can be ascribed to Ca2+-dependent phosphorylation of the P450arom protein (Balthazart et al., , ).
Effect of Melatonin on Neurosteroid Biosynthesis
Measurement of neurosteroid content and/or biosynthesis in the brain of vertebrates has revealed that marked changes in Δ5P, 7α-hydroxypregnenolone (7α-OH-Δ5P), P, THP, and Δ5PS occur during circadian and seasonal cycles (Jo et al., 1990; Takase et al., 1999; Inai et al., 2003; Matsunaga et al., 2004; Tsutsui et al., 2008). These changes often parallel or mirror variations in plasma melatonin concentrations (Hau and Gwinner, 1994; Warren and Cassone, 1995; Marumoto et al., 1996; Murakami et al., 2001). It has been shown that melatonin regulates locomotor activity in house sparrow, Japanese quail, red-bellied newt, ural owl, rock pigeon, and Sprague Dawley rat (Hau and Gwinner, 1994; Warren and Cassone, 1995; Murakami et al., 2001). 7α-OH-Δ5P, in very much the same as melatonin, regulates locomotor activity in Japanese quail and red-bellied newt (Matsunaga et al., 2004; Tsutsui et al., 2008), suggesting that melatonin may control 7α-OH-Δ5P production. In support of this notion, male quails which exhibit marked diurnal variations in locomotor activity also show substantial changes in brain level of 7α-OH-Δ5P while female quails which do not show locomotor rhythms have low level of 7α-OH-Δ5P (Tsutsui et al., 2008). Similarly, it has been found that the synthesis of 7α-OH-Δ5P in the brain of male newts undergoes marked diurnal changes with higher levels during the dark phase when locomotor activity of males is high. In contrast, 7α-OH-Δ5P production in female newts does not change (Haraguchi et al., 2009, 2010; Koyama et al., 2009; Tsutsui et al., 2010). In male quail, suppression of endogenous melatonin through pinealectomy (Px) and orbital enucleation (Ex) causes a significant increase of the expression of CYP7B mRNA and biosynthesis of 7α-OH-Δ5P (Tsutsui et al., 2008). ICV injection of melatonin suppresses the effects of Px and Ex on CYP7B gene transcription and 7α-OH-Δ5P production. Finally, the melatonin receptor antagonist luzindole abrogates the inhibitory effect of melatonin on 7α-OH-Δ5P formation (Tsutsui et al., 2008). Collectively, these data support the contention that, in male birds, melatonin inhibits the expression of CYP7B and that the subsequent decrease of 7α-OH-Δ5P in the brain is responsible for the nocturnal reduction of locomotor activity.
Effect of Prolactin on Neurosteroid Biosynthesis
In male newts, as in many other wild animals, locomotor activity increases during the breeding season (Iwata et al., 2000). This hyperlocomotor response is associated with a concomitant increase in 7α-OH-Δ5P in the newt brain (Haraguchi et al., 2009, 2010). The pituitary hormone prolactin (PRL) exerts pleiotropic functions in the control of reproduction in urodeles (Polzonetti-Magni et al., 1995; Kikuyama et al., 2003). In particular, PRL is involved in migration to water at the breeding season (Chadwick, ) and stimulates expression of courtship behavior with rapid tail vibration by male newts (Toyoda et al., 1993). Indeed, in male newts, plasma PRL concentration increases during the breeding season (Matsuda et al., 1990; Mosconi et al., 1994) and it has been shown that PRL acts centrally to activate courtship behavior (Toyoda et al., 2005), suggesting that PRL may be involved in the control of 7α-OH-Δ5P synthesis in the brain to increase locomotor activity during the reproductive period. In support of this hypothesis, PRL receptor immunoreactivity is observed in CYP7B-expressing neurons in the anterior preoptic area (Poa) and the magnocellular preoptic nucleus (Mg) of the newt brain (Haraguchi et al., 2010). Hypophysectomy markedly reduces brain concentration and biosynthesis of 7α-OH-Δ5P in breeding male newts and these effects are suppressed by ICV injection of PRL (Haraguchi et al., 2010). Reciprocally, ICV administration of newt PRL antiserum dose-dependently decreases 7α-OH-Δ5P synthesis (Haraguchi et al., 2010). Taken together, these observations indicate that PRL directly acts on Mg neurons expressing CYP7B to enhance the biosynthesis of 7α-OH-Δ5P which in turn mediates the stimulatory effect of PRL on locomotion.
Effect of GABA on Neurosteroid Biosynthesis
Gamma-aminobutyric acid (GABA) is the major neurotransmitter in the CNS (Krnjevic and Schwartz, 1966; Meldrum, 1982; Paredes and Agmo, 1992). In mammals, brain nuclei that express steroidogenic enzymes (Tsutsui et al., 1999; Do Rego et al., ) are innervated by GABAergic nerve fibers (Tappaz et al., 1983; Sakaue et al., 1988) and are also enriched with GABAA receptors (De Montis et al., ; McDonald and Mascagni, 1996; Bäckberg et al., ), suggesting that GABA may regulate the activity of steroidogenic nerve cells. As a matter of fact, pharmacological studies have shown that administration of the GABA synthesis inhibitor isoniazid induces an increase of endogenous Δ5P and P in the rat brain (Barbaccia et al., ). In contrast, in rat retinal ganglion cells, GABA, acting through GABAA receptors, stimulates the biosynthesis of Δ5P (Guarneri et al., 1995).
The effect and mechanism of action of GABA in the control of neurosteroidogenesis has been mainly investigated in non-mammalian vertebrate models. Indeed, in amphibians as in mammals, a rich GABAergic innervation (Franzoni and Morino, 1989; Hollis and Boyd, 2005) and a dense accumulation of GABAA receptor subunits (Aller et al., ) have been observed in hypothalamic regions which contain steroidogenic neurons (Mensah-Nyagan et al., 1994, 1999; Tsutsui et al., 1999; Do Rego et al., ). In the frog Rana esculenta, double labeling experiments have shown the presence of GABAA receptor α3 and β2/β3 subunit-like immunoreactivity in 3β-HSD-expressing cell bodies (Figure 1A) in the Poa, the posterior tuberculum, the nucleus of the periventricular organ, and the ventral and dorsal hypothalamic nuclei of the hypothalamus (Do Rego et al., ) suggesting that, in amphibians as in mammals, GABA may play a role in the control of neurosteroid biosynthesis. In agreement with this hypothesis, GABA has been shown to inhibit in a dose-dependent manner de novo biosynthesis of various neurosteroids including 17OH-Δ5P, P, 17OH-P, and DHEA, by frog hypothalamic explants (Do Rego et al., ). The inhibitory effect of GABA on neurosteroid production is mimicked by the GABAA receptor agonist muscimol and is blocked by the selective GABAA receptor antagonists bicuculline and SR95531, but is not affected by the GABAB receptor agonist baclofen (Do Rego et al., ). The observation that bicuculline and SR95531 induce on their own a significant stimulation of steroid formation suggests that endogenous GABA exerts a tonic inhibitory control on neurosteroid-producing neurons (Do Rego et al., ). These data indicate that GABA inhibits the biosynthesis of neurosteroids through activation of GABAA receptors (Figure 1D). Since several neuroactive steroids are potent allosteric regulators of GABAA receptor function in amphibians (Le Foll et al., 1997a,b; Hollis et al., 2004) as in mammals (Majewska, 1992; Belelli and Lambert, ; Belelli et al., ), these observations reveal the existence of an ultrashort feedback loop through which certain neurosteroids may regulate their own production via modulation of GABAA receptor activity (Figure 1D).
Figure 1
Effect of Endozepines on Neurosteroid Biosynthesis
The term endozepines designates a family of endogenous peptides that act as natural ligands of CBRs and peripheral-type benzodiazepine receptors also called translocator protein (TSPO; Tonon et al., 2006). The occurrence of endozepines has been reported in the CNS of all classes of vertebrates including fish (Malagon et al., 1992b; Matsuda et al., 2007), amphibians (Malagon et al., 1992a; Lihrmann et al., 1994), birds (Todaro et al., 1991; Rose et al., 1992), and mammals (Alho et al., ; Tonon et al., 1990; Tong et al., 1991; Malagon et al., 1993). The endozepine family encompasses diazepam-binding inhibitor (DBI), an 86-amino acid polypeptide (Guidotti et al., 1983), and its processing products the triakontatetraneuropeptide (TTN) and the octadecaneuropeptide (ODN; Ferrero et al., ; Slobodyansky et al., 1989). TTN is a selective ligand of TSPO (Slobodyansky et al., 1989; Papadopoulos et al., 2006) while ODN acts as an inverse agonist of CBRs (Ferrero et al., ). Endozepines have been shown to regulate steroid secretion by adrenocortical cells (Yanagibashi et al., 1989; Papadopoulos, 1993; Lesouhaitier et al., 1996, 1998) and Leydig cells (Papadopoulos et al., 1990, 1991a,b; Garnier et al., 1993, 1994; Duparc et al., ). Concurrently, it has been found that TTN stimulates Δ5P biosynthesis by isolated mitochondria from C6 glioma cells (Papadopoulos et al., 1992) indicating that endozepines may be involved in the regulation of neurosteroid production.
The distribution of endozepines has been investigated in the brain of mammals and amphibians by in situ hybridization and immunohistochemistry. In the rat brain, DBI mRNA is expressed in various glial cell populations of the ependyma, area postrema, and cerebellum (Alho et al., ; Tong et al., 1991; Bürgi et al., ). In rat, monkey, and human, endozepine immunoreactivity is found in astrocytes in the arcuate nucleus of the hypothalamus, ependymocytes bordering the third ventricle, tanycytes in the median eminence, pituicytes in the neurohypophysis, and Bergman cells in the cerebellum (Slobodyansky et al., 1992; Malagon et al., 1993; Alho et al., ; Yanase et al., 2002). In the frog R. esculenta, DBI mRNA and ODN-like immunoreactivity are present in radial glial cells of the periventricular systems of the diencephalon and rhombencephalon (Malagon et al., 1992a; Lihrmann et al., 1994). Immunolabeling of consecutive sections revealed that, in the Poa, the dorsal and ventral hypothalamic nuclei, the nucleus of the periventricular organ, and the posterior tuberculum of the frog brain, ODN-immunoreactive ependymocytes project toward 3β-HSD-positive perikarya (Do Rego et al., ; Figures 1B,C). These neuroanatomical observations led us to investigate the possible effects of endozepines on neurosteroid biosynthesis in the diencephalon of amphibians.
Incubation of frog hypothalamic slices with graded concentrations of human and rat ODN induces a dose-dependent stimulation of the conversion of [3H]Δ5P into Δ4-3-ketosteroids and Δ5-3β-hydroxysteroids in vitro (Do Rego et al., ). The biological activity of ODN is borne by the C-terminal portion of the peptide (Do Rego et al., ) whose sequence has been strongly preserved across vertebrate species (Mocchetti et al., 1986; Lihrmann et al., 1994; Tonon et al., 2006). The stimulatory action of ODN on neurosteroid biosynthesis is mimicked by β-carbolines that act as inverse agonists of CBR, and is blocked by the CBR antagonist flumazenil (Do Rego et al., ). The fact that flumazenil alone inhibits the formation of neurosteroids supports the view that ODN plays a physiological role as an endogenous positive modulator of CBR (Do Rego et al., ; Figure 1D).
In intact mammalian endocrine cells, TTN stimulates the secretion of glucocorticoids (Yanagibashi et al., 1989; Papadopoulos et al., 1991a) and testosterone (Garnier et al., 1993; Duparc et al., ). TTN also stimulates steroidogenesis by mitochondria isolated from adrenocortical and testicular Leydig cells (Besman et al., ; Yanagibashi et al., 1989; Papadopoulos et al., 1991a). In frog adrenal tissue, TTN stimulates corticosterone and aldosterone secretion in vitro (Lesouhaitier et al., 1996, 1998). Since TSPO is expressed not only in peripheral organs but also in the CNS (Braestrup and Squires, ; Benavides et al., ,; Anholt et al., ; Richards and Möhler, 1984; Gehlert et al., 1985), these observations suggest that TTN may be involved in the regulation of neurosteroidogenesis. To test this hypothesis, we have investigated the effect of TTN on the biosynthesis of steroids in the brain of amphibians.
Double labeling experiments have shown the presence of TSPO-like immunoreactivity in steroidogenic neurons of the frog Poa and dorsal hypothalamus (Do Rego et al., ; Figure 2A). Exposure of frog hypothalamic fragments to synthetic human TTN causes a concentration-dependent stimulation of the conversion of [3H]Δ5P into 17OH-Δ5P and 17OH-P (Do Rego et al., ). The TSPO agonist Ro5-4864 mimics the stimulatory effect of TTN while the TSPO antagonist PK11195 inhibits TTN-induced steroid production. In contrast, the action of TTN is not impaired by flumazenil, indicating that TTN acts specifically through TSPO to activate neurosteroid biosynthesis (Do Rego et al., ; Figure 2B).
Figure 2
The fact that ODN and TTN, acting via CBR and TSPO, respectively, stimulate the formation of a number of neurosteroids suggests that endozepines should play multiple functions. Indeed, in vivo studies indicate that endozepines, like neurosteroids, exert numerous behavioral effects. In particular, endozepines induce anxiety (Guidotti, 1991; Garcia de Mateos-Verchere et al., 1999), increase aggressivity (Guidotti et al., 1983; Ferrero et al., ; Kavaliers and Hirst, 1986; Guidotti, 1991), and possess anticonvulsant properties (Garcia de Mateos-Verchere et al., 1999). In addition, endozepines are potent anorexigenic neuropeptides (Garcia de Mateos-Verchere et al., 2001; Do Rego et al., ). Since endozepines and neurosteroids are involved in the control of the same behavioral processes, it is conceivable that neurosteroids can mediate some of the neurobiological effects of endozepines.
Effects of Vasotocin and Mesotocin on Neurosteroid Biosynthesis
Anatomical studies support the existence of neurochemical communication between steroidogenic neurons on the one hand, and neurons producing either arginine vasopressin (AVP) and oxytocin (OXT) in mammals or their orthologs arginine vasotocin (AVT) and mesotocin (MT) in submammalian vertebrates on the other hand. For instance, in birds, AVT-immunoreactive fibers innervate aromatase-expressing neurons in the preoptic nucleus and the lateral septum (Viglietti-Panzica et al., 1994; Balthazart, ). In the brain of amphibians, AVT- and/or MT-containing fibers project in the vicinity of 3β-HSD- and P450C17-positive neurons (Do Rego et al., ; Figure 3A). In addition, the Poa, the dorsal and ventral hypothalamic nuclei, the suprachiasmatic nucleus, the posterior tuberculum, the nucleus of the periventricular organ, and the ventral part of the magnocellular preoptic nucleus of the frog diencephalon that contain the major populations of steroidogenic neurons are also enriched with AVP and MT receptor mRNAs. These close neuroanatomical relationships led us to investigate the possible effects of AVT and MT on neurosteroid biosynthesis in amphibians.
Figure 3
Static incubation of frog hypothalamic explants with AVT or MT stimulates the biosynthesis of 17OH-Δ5P, P, 17OH-P, and DHEA in a concentration-dependent manner (Do Rego et al., ). This stimulatory effect is observed within the first 30-min, indicating that AVT and MT act at the post-translational level, possibly by activating phosphorylation of steroidogenic enzymes. The mammalian peptides AVP and OXT also induce a dose-related stimulation of neurosteroid biosynthesis (Do Rego et al., ). Pharmacological studies conducted with specific AVT and MT agonists and antagonists revealed that the effect of AVT and MT are mediated through V1a and MT receptors, respectively (Do Rego et al., ; Figure 3B). These observations are in agreement with the intense expression of V1a and MT receptor mRNAs in the hypothalamic nuclei that contain neurosteroidogenic neurons (Do Rego et al., ). Interestingly, in frog adrenocortical cells, AVT is also a potent stimulator of corticosteroid secretion although, in this latter case, AVT acts via V2 receptors (Larcher et al., 1989, 1992).
In vertebrates, AVP and related peptides exert a vast array of biological effects in the CNS (De Wied et al., ; Reghunandanan et al., 1998). For instance, in mammals, AVP enhances learning and memory (Alescio-Lautier and Soumireu-Mourat, ; Croiset et al., ; Engelmann et al., ; Engelmann, ) and increases aggressivity and anxiety-like behaviors (Ferris et al., ; Everts and Koolhaas, ; Heinrichs and Domes, 2008; Amikishieva et al., ; Mak et al., 2011; Meyer-Lindenberg et al., 2011). In birds, depending of the species, AVT increases or attenuates aggressive behavior (Goodson et al., 2004, 2009; Dewan et al., ). In amphibians, AVT stimulates vocalization and courtship behavior (Woolley et al., 2004; Moore et al., 2005; Thompson et al., 2008; Kikuyama et al., 2009). Certain neurosteroids also affect cognitive and mnemonic functions, aggressiveness and sexual activity (Frye, 2001; Vallée et al., 2001; Darnaudery et al., ; MacKenzie et al., 2007; Morrow, 2007). It thus appears that some of the behavioral effects of AVP/AVT may be ascribed to their stimulatory action on neurosteroid biosynthesis.
Effect of Neuropeptide Y on Neurosteroid Biosynthesis
Hydroxysteroid sulfotransferase (HST) catalyzes the transfer of a sulfate moiety from 3′-phosphoadenosine 5′-phosphosulfate (PAPS, a universal donor of sulfate radical) on the 3-hydroxyl group of steroids (Klaassen and Boles, 1997; Strott, 2002). While the presence of HST-containing neurons has been clearly demonstrated in the amphibian hypothalamus (Beaujean et al., ; Vaudry et al., 2011), the existence of HST in the brain of mammals is still a matter of debate (Geese and Raftogianis, 2001; Shimada et al., 2001; Shimizu et al., 2003; Kohjitani et al., 2006). Neuropeptide Y (NPY) is one of the most widely distributed biologically active peptides in the CNS of vertebrates (Allen et al., ; De Quidt and Emson, ; Bons et al., ; Danger et al., , ; Aste et al., ; Hendry, 1993) and NPY, like sulfated neurosteroids, exerts a wide range of neurobiological activities (Dumont and Quirion, ).
In frog, the Poa and the magnocellular preoptic nucleus where HST-positive cell bodies are located (Beaujean et al., ; Do Rego et al., ) are abundantly innervated by NPY-immunoreactive fibers (Danger et al., ), suggesting that NPY could play a role in the regulation of HST-expressing neurons. In support of this hypothesis, double labeling experiments revealed that, in the frog diencephalon, numerous NPYergic axon terminals are apposed onto HST-containing perikarya (Beaujean et al., ; Figure 4A). In addition, the mRNAs encoding the Y1 and Y5 NPY receptor subtypes are expressed in the Poa and the magnocellular preoptic nucleus (Beaujean et al., ). Incubation of frog hypothalamic tissue with [3H]Δ5P or [3H]DHEA as steroid precursors and [35S]PAPS as a sulfate donor leads to the biosynthesis of [3H, 35S]Δ5PS or [3H, 35S]DHEAS, respectively, confirming the existence of a biologically active form of HST in the amphibian brain (Beaujean et al., ). Synthetic frog NPY (Chartrel et al., ) causes a concentration-dependent inhibition of the de novo formation of Δ5PS and DHEAS (Beaujean et al., ). The inhibitory effect of NPY is suppressed by the Y1 receptor antagonist BIBP3226 while the Y2 receptor antagonist NPY(13–36) is totally inactive (Beaujean et al., ). The fact that the Y1 receptor antagonist per se slightly increases the biosynthesis of Δ5PS and DHEAS reveals that endogenous NPY likely acts as a physiological modulator of the formation of sulfated neurosteroids (Beaujean et al., ). These data, together with the observation that Y1 receptor mRNA is expressed in the Poa and the dorsal magnocellular nucleus, provide strong evidence for a Y1-mediated inhibitory action of NPY on the biosynthesis of sulfated neurosteroids (Figure 4B).
Figure 4
Neuropeptide Y and sulfated neurosteroids are known to regulate the same behavioral activities including response to novelty (von Horsten et al., 1998; Tasan et al., 2009), feeding and satiety (Kalra and Kalra, 2004a,b; Ramos et al., 2005; Beck, ; Ueno et al., 2008), and reproductive behavior (Wehrenberg et al., 1989). NPY and sulfated neurosteroids are also implicated in the physiopathology of cognitive disorders, pain, epilepsy, anxiety, and depression (Engel and Grant, ; Rupprecht and Holsboer, 2001; Dumont and Quirion, ; Gibbs et al., 2006; Reddy, 2010; Thorsell, 2010; Nguyen et al., 2011). The fact that NPY reduces the biosynthesis of sulfated neurosteroids would thus indicate that some of the neurophysiological activities of NPY could be attributed to inhibition of HST activity.
Concluding Remarks
Studies conducted over the last decade have shown that the biosynthesis of neurosteroids is finely regulated by neurotransmitters (melatonin, GABA), pituitary hormones (prolactin), and various neuropeptides (ODN, TTN, AVT, MT, NPY). Several projects are currently in progress and there is little doubt that additional factors involved in the control of neurosteroid formation will be identified in the near future. As illustrated in the present report, most of the studies aimed at identifying the neurochemical regulation of neurosteroid biosynthesis have been conducted in non-mammalian models, mainly birds and amphibians. It will be now essential to examine whether the same mechanisms are operating in the brain of mammals and to look for their potential physiopathological significance. Little is currently known regarding the molecular mechanisms implicated in the regulation of neurosteroid biosynthesis. In particular, it has to be determined whether the neuroendocrine factors controlling neurosteroid production act at the transcriptional level to regulate the expression of the genes encoding the steroidogenic enzymes or at the post-translational level, e.g., to modulate the phosphorylation and thus the activity of these enzymes. The fact that neurosteroids are usually implicated in the same biological processes as the neuroendocrine factors which regulate their biosynthesis strongly suggests that some of the neurophysiological and behavioral activities of these latter factors could be mediated by neurosteroids. To test this hypothesis, it will be necessary to investigate whether specific activities of these regulatory factors are impaired in conditional KO mice lacking selectively expression of steroidogenic enzymes in the brain. The neuroendocrine regulation of neurosteroid biosynthesis by neurotransmitters, neuropeptides, and hormonal factors is currently an emerging theme that will undoubtedly flourish in the years to come.
Statements
Acknowledgments
This work was supported by grants from the Institut National de la Santé et de la Recherche Médical (INSERM U413/U982), the Ministère des Affaires Etrangères (France–Québec exchange program to Georges Pelletier and Hubert Vaudry), a France–Québec exchange program (INSERM-Fonds de la Recherche en Santé du Québec, FRSQ, to Georges Pelletier and Hubert Vaudry), France–Korean exchange programs (INSERM-Korea Science and Engineering Foundation, KOSEF, to Jae Young Seong and Hubert Vaudry; and Science and Technology Amicable Relationships, STAR, to Jean Luc Do Rego, Jae Young Seong, and Hubert Vaudry), a France–Japan exchange program (INSERM-Japan Society for the Promotion of Science, JSPS, to Kazuyoshi Tsutsui, Hubert Vaudry, and Jean Luc Do Rego), the Plate-Forme Régionale de Recherche en Imagerie Cellulaire de Haute-Normandie (PRIMACEN), and the Région Haute-Normandie. Hubert Vaudry is Associated Researcher at the Research Center in Molecular Endocrinology, Oncology and Genetics, Laval University, Québec.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
Alescio-LautierB.Soumireu-MouratB. (1998). Role of vasopressin in learning and memory in the hippocampus. Prog. Brain Res.119, 501–521.10.1016/S0079-6123(08)61590-3
2
AlhoH.BovolinP.JenkinsD.GuidottiA.CostaE. (1989). Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain. J. Chem. Neuroanat.2, 301–318.
3
AlhoH.FremeauR. T.Jr.TiedgeH.WilcoxJ.BovolinP.BroslusJ.RobertsJ. L.CostaE. (1988). Diazepam binding inhibitor gene expression: location in brain and peripheral tissues of rat. Proc. Natl. Acad. Sci. U.S.A.85, 7018–7022.10.1073/pnas.85.18.7018
4
AlhoH.KolmerM.HarjuntaustaT.HelenP. (1995). Increased expression of diazepam binding inhibitor in human brain tumors. Cell Growth Differ.6, 309–314.
5
AllenY. S.AdrianT. E.AllenJ. M.TatemotoK.CrowT. J.BloomS. R.PolakJ. M. (1983). Neuropeptide Y distribution in the rat brain. Science221, 877–879.10.1126/science.6136091
6
AllerM. I.JanusonisS.FiteK. V.Fernández-LópezA. (1997). Distribution of the GABAA receptor complex β2/3 subunits in the brain of the frog Rana pipiens. Neurosci. Lett.225, 65–68.10.1016/S0304-3940(97)00191-2
7
AmikishievaA. V.IlnitskayaS. I.NikolinV. P.PopovaN. A. (2011). Effect of vasopressin V1B receptor antagonist, SSR149415, on anxiety-like behavior and Lewis lung carcinoma metastasis in mice. Exp. Oncol.33, 126–129.
8
AnholtR. R.MurphyK. M.MackG. E.SnyderS. H. (1984). Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves. J. Neurosci.4, 593–603.
9
AsteN.Viglietti-PanzicaC.FasoloA.AndreoneC.VaudryH.PelletierG.PanzicaG. C. (1991). Localization of neuropeptide Y-immunoreactive cells and fibres in the brain of the Japanese quail. Cell Tissue Res.265, 219–230.10.1007/BF00398070
10
BäckbergM.UlteniusC.FritschyJ. M.MeisterB. (2004). Cellular localization of GABA receptor α subunit immunoreactivity in the rat hypothalamus: relationship with neurons containing orexigenic or anorexigenic peptides. J. Neuroendocrinol.16, 589–604.10.1111/j.1365-2826.2004.01207.x
11
BalthazartJ. (1997). Steroid control and sexual differentiation of brain aromatase. J. Steroid Biochem. Mol. Biol.61, 323–339.10.1016/S0960-0760(97)80030-1
12
BalthazartJ.BaillienM.BallG. F. (2001a). Rapid and reversible inhibition of brain aromatase activity. J. Neuroendocrinol.13, 63–73.10.1111/j.1365-2826.2001.00598.x
13
BalthazartJ.BaillienM.BallG. F. (2001b). Phosphorylation processes mediate rapid changes of brain aromatase activity. J. Steroid Biochem. Mol. Biol.79, 261–277.10.1016/S0960-0760(01)00143-1
14
BalthazartJ.BaillienM.CharlierT. D.CornilC. A.BallG. F. (2001c). Multiple mechanisms control brain aromatase activity at the genomic and non-genomic level. J. Steroid Biochem. Mol. Biol.86, 367–379.10.1016/S0960-0760(03)00346-7
15
BalthazartJ.BaillienM.CharlierT. D.BallG. F. (2003). Calcium-dependent phosphorylation processes control brain aromatase in quail. Eur. J. Neurosci.17, 1591–1606.10.1046/j.1460-9568.2003.02598.x
16
BarbacciaM. L.RoscettiG.TrabucchiM.PurdyR. H.MostallinoM. C.PerraC.ConcasA.BiggioG. (1996). Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain. Neuropharmacology35, 1299–1305.10.1016/S0028-3908(96)00067-6
17
BaulieuE. E. (1997). Neurosteroids: of the nervous system by the nervous system, for the nervous system. Recent Prog. Horm. Res.52, 1–32.
18
BaulieuE. E. (1998). Neurosteroids: a novel function of the brain. Psychoneuroendocrinology23, 963–987.10.1016/S0306-4530(98)00071-7
19
BaulieuE. E.RobelP.SchumacherM. (1999). “Neurosteroids: a new regulatory function in the nervous system,” eds BaulieuE. E.RobelP.SchumacherM. (Totowa, NJ: Humana Press), 1–26.
20
BeaujeanD.Do RegoJ. L.GalasL.Mensah-NyaganA. G.FredrikssonR.LarhammarD.FournierA.Luu-TheV.PelletierG.VaudryH. (2002). Neuropeptide Y inhibits the biosynthesis of sulfated neurosteroids in the hypothalamus through activation of Y1 receptors. Endocrinology143, 1950–1963.10.1210/en.143.5.1950
21
BeaujeanD.Mensah-NyaganA. G.Do RegoJ. L.Luu-TheV.PelletierG.VaudryH. (1999). Immunocytochemical localization and biological activity of hydroxysteroid sulfotransferase in the frog brain. J. Neurochem.72, 848–857.10.1046/j.1471-4159.1999.720848.x
22
BeckB. (2006). Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos. Trans. R. Soc. Lond. B Biol. Sci.361, 1159–1185.10.1098/rstb.2006.1855
23
BelelliD.BolgerM. B.GeeK. W. (1989). Anticonvulsant profile of the progesterone metabolite 3α-hydroxy 5α-pregnan-20-one. Eur. J. Pharmacol.166, 325–329.10.1016/0014-2999(89)90077-0
24
BelelliD.HerdM. B.MitchellE. A.PedenD. R.VardyA. W.GentetL.LambertJ. J. (2006). Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience138, 821–829.10.1016/j.neuroscience.2005.07.021
25
BelelliD.LambertJ. J. (2005). Neurosteroids: endogenous regulators of the GABAA receptor. Nat. Rev. Neurosci.6, 565–575.10.1038/nrn1703
26
BenavidesJ.QuarteronetD.ImbaultF.MalgourisC.UzanA.RenaultC.DubroeucqM. C.GueremyC.Le FurG. (1983a). Labelling of “peripheral-type” benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem.41, 1744–1750.10.1111/j.1471-4159.1983.tb00888.x
27
BenavidesJ.MalgourisC.ImbaultF.BegassatF.UzanA.RenaultC.DubroeucqM. C.GueremyC.Le FurG. (1983b). “Peripheral type” benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization. Arch. Int. Pharmacodyn. Ther.266, 38–49.
28
BergeronR.de MontignyC.DebonnelG. (1996). Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci.16, 1193–1202.
29
BesmanM. J.YanagibashiK.LeeT. D.KawamuraM.HallP. F.ShivelyJ. E. (1989). Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A.86, 4897–4901.10.1073/pnas.86.13.4897
30
BonsN.MestreN.PetterA.DangerJ. M.PelletierG.VaudryH. (1990). Localization and characterization of neuropeptide Y in the brain of Microcebus murinus (Primate, Lemurian). J. Comp. Neurol.298, 343–361.10.1002/cne.902980307
31
BowlbyM. R. (1993). Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol.43, 813–819.
32
BraestrupC.SquiresR. F. (1977). Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc. Natl. Acad. Sci. U.S.A.74, 3805–3809.10.1073/pnas.74.9.3805
33
BullockA. E.ClarkA. L.GradyS. R.RobinsonS. F.SlobeB. S.MarksM. J.CollinsA. C. (1997). Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J. Neurochem.68, 2412–2423.10.1046/j.1471-4159.1997.68062412.x
34
BürgiB.LichtensteigerW.LauberM. E.SchlumpfM. (1999). Ontogeny of diazepam binding inhibitor/acyl-CoA binding protein mRNA and peripheral benzodiazepine receptor mRNA expression in the rat. J. Neuroendocrinol.11, 85–100.10.1046/j.1365-2826.1999.00292.x
35
ChadwickC. S. (1941). Identity of prolactin with water drive factor in Triturus viridescens. Proc. Soc. Exp. Biol. Med.45, 335–337.
36
CharalampopoulosI.TsatsanisC.DermitzakiE.AlexakiV. I.CastanasE.MargiorisA. N.GravanisA. (2004). Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A.101, 8209–8214.10.1073/pnas.0306631101
37
ChartrelN.ConlonJ. M.DangerJ. M.FournierA.TononM. C.VaudryH. (1991). Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc. Natl. Acad. Sci. U.S.A.88, 3862–3866.10.1073/pnas.88.9.3862
38
CompagnoneN. A.MellonS. H. (1998). Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U.S.A.95, 4678–4683.10.1073/pnas.95.8.4678
39
CompagnoneN. A.MellonS. H. (2000). Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol.21, 1–56.10.1006/frne.1999.0188
40
CornilC.FoidartA.MinetA.BalthazartJ. (2000). Immunocytochemical localization of ionotropic glutamate receptors subunits in the adult quail forebrain. J. Comp. Neurol.428, 577–608.10.1002/1096-9861(20001225)428:4<577::AID-CNE1>3.3.CO;2-B
41
CornilC. A. (2009). Rapid regulation of brain oestrogen synthesis: the behavioural roles of oestrogens and their fates. J. Neuroendocrinol.21, 217–226.10.1111/j.1365-2826.2009.01822.x
42
CorpéchotC.RobelP.AxelsonM.SjövallJ.BaulieuE. E. (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U.S.A.78, 4704–4707.10.1073/pnas.78.8.4704
43
CorpéchotC.SynguelakisM.TalhaS.AxelsonM.SjövallJ.VihkoR.BaulieuE. E.RobelP. (1983). Pregnenolone and its sulfate ester in the rat brain. Brain Res.270, 119–125.10.1016/0006-8993(83)90797-7
44
CostaE. T.SotoE. E.CardosoR. A.OliveraD. S.ValenzuelaC. F. (2000). Acute effects of ethanol on kainate receptors in cultured hippocampal neurons. Alcohol. Clin. Exp. Res.24, 220–225.10.1111/j.1530-0277.2000.tb04594.x
45
CroisetG.NijsenM. J. M. A.KamphuisP. J. G. H. (2000). Role of corticotrophin-releasing factor, vasopressin and autonomic nervous system in learning and memory. Eur. J. Pharmacol.405, 225–234.10.1016/S0014-2999(00)00556-2
46
DamianischK.RupprechtR.LancelM. (2001). The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology25, 576–584.10.1016/S0893-133X(01)00242-1
47
DangerJ. M.BretonB.VallarinoM.FournierA.PelletierG.VaudryH. (1991). Neuropeptide-Y in the trout brain and pituitary: localization, characterization, and action on gonadotropin release. Endocrinology128, 2360–2368.10.1210/endo-128-5-2360
48
DangerJ. M.GuyJ.BenyaminaJ.JégouS.LeboulengerF.CotéJ.TononM. C.PelletierG.VaudryH. (1985). Localization and identification of neuropeptide Y (NPY)-like immunoreactivity in the frog brain. Peptides6, 1225–1236.10.1016/0196-9781(85)90455-3
49
DangerJ. M.TononM. C.JenksB. G.Saint-PierreS.MartelJ. C.FasoloA.BretonB.QuirionR.PelletierG.VaudryH. (1990). Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fundam. Clin. Pharmacol.4, 307–340.10.1111/j.1472-8206.1990.tb00497.x
50
DarnauderyM.PallarèsM.PiazzaP. V.Le MoalM.MayoW. (2002). The neurosteroid pregnenolone sulfate infused into the medial septum nucleus increases hippocampal acetylcholine and spatial memory in rats. Brain Res.95, 237–242.10.1016/S0006-8993(02)03166-9
51
De MontisG. M.OlianasM. C.MulasG.LloydK. G.TagliamonteA. (1981). GABA receptors distribution in rat substantia nigra. Neurosci. Lett.23, 257–261.10.1016/0304-3940(81)90007-0
52
De QuidtM. E.EmsonP. C. (1986). Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system II. Immunohistochemical analysis. Neuroscience18, 545–618.10.1016/0306-4522(86)90057-6
53
De WiedD.DiamantM.FodorM. (1993). Central nervous system effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol.14, 251–302.10.1006/frne.1993.1009
54
DewanA. K.RameyM. L.TricasT. C. (2011). Arginine vasotocin neuronal phenotypes, telencephalic fiber varicosities, and social behavior in butterflyfishes (Chaetodontidae): potential similarities to birds and mammals. Horm. Behav.59, 56–66.10.1016/j.yhbeh.2010.10.002
55
DiotelN.Do RegoJ. L.AngladeI.VaillantC.PellegriniE.GueguenM. M.MironovS.VaudryH.KahO. (2011). Activity and expression of steroidogenic enzymes in the brain of adult zebrafish. Eur. J. Neurosci.34, 45–56.10.1111/j.1460-9568.2011.07731.x
56
DiotelN.Le PageY.MouriecK.TongS. K.PellegriniE.VaillantC.AngladeI.BrionF.PakdelF.ChungB. C.KahO. (2010). Aromatase in the brain of teleost fish: expression, regulation and putative functions. Front. Neuroendocrinol.31, 172–192.10.1016/j.yfrne.2010.01.003
57
DjebailiM.HoffmanS. W.SteinD. G. (2004). Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience123, 349–359.10.1016/j.neuroscience.2003.09.023
58
Do RegoJ. C.OrtaM. H.LeprinceJ.TononM. C.VaudryH.CostentinJ. (2007). Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology32, 1641–1648.10.1038/sj.npp.1301280
59
Do RegoJ. L.AcharjeeS.SeongJ. Y.GalasL.AlexandreD.BizetP.BurletA.KwonH. B.Luu-TheV.PelletierG.VaudryH. (2006). Vasotocin and mesotocin stimulate the biosynthesis of neurosteroids in the frog brain. J. Neurosci.26, 6749–6760.10.1523/JNEUROSCI.4469-05.2006
60
Do RegoJ. L.Mensah-NyaganA. G.BeaujeanD.LeprinceJ.TononM. C.Luu-TheV.PelletierG.VaudryH. (2001). The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors. J. Neurochem.76, 128–138.10.1046/j.1471-4159.2001.00053.x
61
Do RegoJ. L.Mensah-NyaganA. G.BeaujeanD.VaudryD.SieghartW.Luu-TheV.PelletierG.VaudryH. (2000). GABA, acting through GABAA receptors, inhibits biosynthesis of neurosteroids in the frog hypothalamus. Proc. Natl. Acad. Sci. U.S.A.97, 13925–13930.10.1073/pnas.240269897
62
Do RegoJ. L.Mensah-NyaganA. G.FeuilloleyM.FerraraP.PelletierG.VaudryH. (1998). The endozepine triakontatetraneuropeptide diazepam-binding inhibitor [17-50] stimulates neurosteroid biosynthesis in the frog hypothalamus. Neuroscience83, 555–570.10.1016/S0306-4522(97)00362-X
63
Do RegoJ. L.SeongJ. Y.BurelD.LeprinceJ.Luu-TheV.TsutsuiK.TononM. C.PelletierG.VaudryH. (2009). Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol.30, 259–301.10.1016/j.yfrne.2009.05.006
64
Do RegoJ. L.TremblayY.Luu-TheV.RepettoE.CastelH.VallarinoM.BélangerA.PelletierG.VaudryH. (2007a). Immunohistochemical localization and biological activity of the steroidogenic enzyme cytochrome P450 17α-hydroxylase/C17, 20-lyase (P450C17) in the frog brain and pituitary. J. Neurochem.100, 251–268.10.1111/j.1471-4159.2006.04209.x
65
Do RegoJ. L.LeprinceJ.Luu-TheV.PelletierG.TononM. C.VaudryH. (2007b). Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN11–18) on neurosteroid biosynthesis by hypothalamic explants. J. Med. Chem.50, 3070–3076.10.1021/jm0610548
66
DubrovskyB. O. (2005). Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry29, 169–192.10.1016/j.pnpbp.2004.11.001
67
DumontY.QuirionR. (2006). “Neuropeptide Y,” in Handbook of Biologically Active Peptides, ed. KastinA. J. (New York: Academic Press), 683–688.
68
DuparcC.LefebvreH.TononM. C.VaudryH.KuhnJ. M. (2003). Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion. J. Clin. Endocrinol. Metab.88, 5521–5528.10.1210/jc.2003-030783
69
EngelS. R.GrantK. A. (2001). Neurosteroids and behavior. Int. Rev. Neurobiol.46, 321–348.10.1016/S0074-7742(01)46067-3
70
EngelmannM. (2008). Vasopressin in the septum: not important versus causally involved in learning and memory – two faces of the same coin?Prog. Brain Res.170, 389–395.10.1016/S0079-6123(08)00432-9
71
EngelmannM.WotjakC. T.EbnerK.LandgrafR. (2000). Behavioral impact of intraseptally released vasopressin and oxytocin in rats. Exp. Physiol.85, 125S–130S.10.1017/S0958067000019497
72
EvertsH. G. J.KoolhaasJ. M. (1999). Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxiety-related behaviors in rats. Behav. Brain Res.99, 7–16.10.1016/S0166-4328(98)00004-7
73
FaheyJ. M.MillerL. G.IsaacsonR. L. (1995a). Neurosteroid modulation of locomotor activity in mice. Neurosci. Res. Commun.17, 159–167.
74
FaheyJ. M.LindquistD. G.PritchardG. A.MillerL. G. (1995b). Pregnenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res.669, 183–188.10.1016/0006-8993(94)01223-5
75
FerreroP.GuidottiA.Conti-TronconiB. (1984). A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology23, 1359–1362.10.1016/0028-3908(84)90061-3
76
FerrisC. F.MelloniR. H.Jr.KoppelG.PerryK. W.FullerR. W.DelvilleY. (1997). Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J. Neurosci.17, 4331–4340.
77
FloodJ. F.MorleyJ. E.RobertsE. (1992). Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. U.S.A.89, 1567–1571.10.1073/pnas.89.5.1567
78
FloodJ. F.SmithG. E.RobertsE. (1988). Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res.447, 269–278.10.1016/0006-8993(88)91129-8
79
FrankC.SagratellaS. (2000). Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog. Neuropsychopharmacol. Biol. Psychiatry24, 1117–1126.10.1016/S0278-5846(00)00124-X
80
FranzoniM. F.MorinoP. (1989). The distribution of GABA-like-immunoreactive neurons in the brain of the newt, Tritucus cristatus carnifex, and the green frog Rana esculenta. Cell Tissue Res.255, 155–166.10.1007/BF00229077
81
FryeC. A. (2001). The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Rev.37, 201–222.10.1016/S0165-0173(01)00119-9
82
Garcia de Mateos-VerchereJ.LeprinceJ.TononM. C.VaudryH.CostentinJ. (1999). Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN. Peptides20, 1431–1436.10.1016/S0196-9781(99)00153-9
83
Garcia de Mateos-VerchereJ.LeprinceJ.TononM. C.VaudryH.CostentinJ. (2001). The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur. J. Pharmacol.414, 225–231.10.1016/S0014-2999(01)00771-3
84
GarnierM.BoujradN.OgwuegbuS. O.HudsonJ. R.Jr.PapadopoulosV. (1994). The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem.269, 22105–22112.
85
GarnierM.BoujradN.OkeB. O.BrownA. S.RiondJ.FerraraP.ShoyabM.Suarez-QuianC. A.PapadopoulosV. (1993). Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology132, 444–458.10.1210/en.132.1.444
86
GeeseW. J.RaftogianisR. B. (2001). Biochemical characterization and tissue distribution of human SULT2B1. Biochem. Biophys. Res. Commun.288, 280–289.10.1006/bbrc.2001.5746
87
GehlertD. R.YamamuraH. I.WamsleyJ. K. (1985). Autoradiographic localization of “peripheral-type” benzodiazepine binding sites in the rat brain, heart and kidney. Naunyn Schmiedebergs Arch. Pharmacol.328, 454–460.10.1007/BF00692915
88
GibbsJ. L.FloresC. M.HargreavesK. M. (2006). Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain124, 167–174.10.1016/j.pain.2006.04.013
89
GoodsonJ. L.KabelikD.SchrockS. E. (2009). Dynamic neuromodulation of aggression by vasotocin: influence of social context and social phenotype in territorial songbirds. Biol. Lett.5, 554–556.10.1098/rsbl.2009.0316
90
GoodsonJ. L.LindbergL.JohnsonP. (2004). Effects of central vasotocin and mesotocin manipulations on social behavior in male and female zebra finches. Horm. Behav.45, 136–143.10.1016/j.yhbeh.2003.08.006
91
GrazziniE.GuillonG.MouillacB.ZinggH. H. (1998). Inhibition of oxytocin receptor function by direct binding of progesterone. Nature392, 509–512.10.1038/33176
92
GuarneriP.GuarneriR.CascioC.PiccoliF.PapadopoulosV. (1995). γ-aminobutyric acid type A/benzodiazepine receptors regulate rat retina neurosteroidogenesis. Brain Res.683, 65–72.10.1016/0006-8993(95)00343-O
93
GuidottiA. (1991). Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior. Neuropharmacology30, 1425–1433.10.1016/S0028-3908(11)80012-2
94
GuidottiA.ForchettiC. M.CordaM. G.KondelD.BennettC. D.CostaE. (1983). Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. U.S.A.80, 3531–3535.10.1073/pnas.80.11.3531
95
GursoyE.CardounelA.KalimiA. (2001). Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem. Res.26, 15–21.10.1023/A:1007668213330
96
HaradaN. (1988). Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J. Biochem.103, 106–113.
97
HaraguchiS.KoyamaT.Do RegoJ. L.TsutsuiK. (2009). Seasonal changes in the synthesis of 7α-hydroxypregnenolone stimulating locomotor activity in newts. Ann. N. Y. Acad. Sci.1163, 410–413.10.1111/j.1749-6632.2008.03621.x
98
HaraguchiS.KoyamaT.HasunumaI.VaudryH.TsutsuiK. (2010). Prolactin increases the synthesis of 7α-hydroxypregnenolone, a key factor for induction of locomotor activity, in breeding male newts. Endocrinology151, 2211–2222.10.1210/en.2009-1229
99
HauM.GwinnerE. (1994). Melatonin facilitates synchronization of sparrow circadian rhythms to light. J. Comp. Physiol. A175, 343–347.10.1007/BF00192993
100
HeJ.HoffmanS. W.SteinD. G. (2004). Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor. Neurol. Neurosci.22, 19–31.
101
HeinrichsM.DomesG. (2008). Neuropeptides and social behavious: effect of oxytocin and vasopressin in humans. Prog. Brain Res.170, 337–350.10.1016/S0079-6123(08)00428-7
102
HendryS. H. (1993). “Organization of neuropeptide Y neurons in the mammalian central nervous system,” in The Biology of Neuropeptide Y and Related Peptides, eds ColmersW. F.WahlestedC. (Totowa, NJ: Humana Press), 65–156.
103
HodgeC. W.RaberJ.McMahonT.WalterH.Sanchez-PerezA. M.OliveM. F.MehmertK.MorrowA. L.MessingR. O. (2002). Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest.110, 1003–1010.10.1172/JCI15903
104
HollisD. M.BoydS. K. (2005). Distribution of GABA-like immunoreactive cell bodies in the brains of two amphibians, Rana catesbeiana and Xenopus laevis. Brain Behav. Evol.65, 127–142.10.1159/000082981
105
HollisD. M.GoetzF. W.RobertsS. B.BoydS. K. (2004). Acute neurosteroid modulation and subunit isolation of the gamma-aminobutyric acidA receptor in the bullfrog, Rana catesbeina. J. Mol. Endocrinol.32, 921–934.10.1677/jme.0.0320921
106
HorishitaT.MinamiK.UezonoY.ShiraishiM.OgataJ.OkamotoT.TeradaT.SataT. (2005). The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors. Naunyn Schmiedebergs Arch. Pharmacol.371, 221–228.10.1007/s00210-005-1022-1
107
HuY.CardounelA.GursoyE.AndersonP.KalimiM. (2000). Anti-stress effects of dehydroepiandrosterone: protection of rats against repeated immobilization stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation. Biochem. Pharmacol.59, 753–762.10.1016/S0006-2952(99)00385-8
108
InaiY.NagaiK.UkenaK.OishiT.TsutsuiK. (2003). Seasonal changes in neurosteroid concentrations in the amphibian brain and environmental factors regulating their changes. Brain Res.959, 214–225.10.1016/S0006-8993(02)03745-9
109
IrwinR. P.MaragakisN. J.RogawskiM. A.PurdyR. H.FarbD. H.PaulS. M. (1992). Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons. Neurosci. Lett.141, 30–34.10.1016/0304-3940(92)90327-4
110
IwataM.MuneokaK. T.ShirayamaY.YamamotoA.KawaharaR. (2005). A study of a dendritic marker, microtubule-associated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA). Neurosci. Lett.386, 145–149.10.1016/j.neulet.2005.06.004
111
IwataT.ToyodaF.YamamotoK.KikuyamaS. (2000). Hormonal control of urodele reproductive behavior. Comp. Biochem. Physiol. B. Biochem. Mol. Biol.126, 221–229.10.1016/S0305-0491(00)00200-5
112
JiangP.YangC. X.WangY. T.XuT. L. (2006). Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat. Neuroscience141, 2041–2050.10.1016/j.neuroscience.2006.05.009
113
JoD. H.Sánchez de la PeñaS.HalbergF.UngarF.BaulieuE. E.RobelP. (1990). Circadian-infradian rhythmic variation of brain neurosteroids in the female rat. Prog. Clin. Biol. Res.341B, 125–134.
114
JonesK. (1994). Androgenic enhancement of motor neuron regeneration. Ann. N. Y. Acad. Sci.743, 141–164.10.1111/j.1749-6632.1994.tb55791.x
115
KalraS. P.KalraP. S. (2004a). NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides38, 201–211.10.1016/j.npep.2004.06.003
116
KalraS. P.KalraP. S. (2004b). NPY: an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction. Peptides25, 465–471.10.1016/j.peptides.2004.03.001
117
KaurG.KulkarniS. K. (2001). Subchronic studies on modulation of feeding behavior and body weight by neurosteroids in female mice. Methods Find. Exp. Clin. Pharmacol.23, 115–119.10.1358/mf.2001.23.3.627942
118
KavaliersM.HirstM. (1986). An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice. Brain Res.383, 343–349.10.1016/0006-8993(86)90037-5
119
KavaliersM.KinsellaD. M. (1995). Male preference for the odors of estrous female mice is reduced by the neurosteroid pregnenolone sulfate. Brain Res.682, 222–226.10.1016/0006-8993(95)00335-N
120
KikuyamaS.HasunumaI.ToyodaF.HaraguchiS.TsutsuiK. (2009). Hormone-mediated reproductive behavior in the red-bellied newt. Ann. N. Y. Acad. Sci.1163, 79–86.10.1111/j.1749-6632.2009.04449.x
121
KikuyamaS.TanakaS.MooreF. L. (2003). “Reproductive biology and phylogeny of urodela,” in Endocrinology of Reproduction, ed. SeverD. M. (Enfield, NH: Science Publishers), 275–321.
122
KimonidesV. G.KhatibiN. H.SvendsenC. N.SofroniewM. V.HerbertJ. (1998). Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A.95, 1852–1857.10.1073/pnas.95.4.1852
123
KimonidesV. G.SpillantiniM. G.SofroniewM. V.fawcettJ. W.HerbertJ. (1999). Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience89, 429–436.10.1016/S0306-4522(98)00347-9
124
KlaassenC. D.BolesJ. W. (1997). Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J.11, 404–418.
125
KoenigH. L.SchumacherM.FerzazB.DoT. A. N.RessouchesA.GuennounR.Jung-TestasI.RobelP.AkwaY.BaulieuE. E. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science268, 1500–1503.10.1126/science.7770777
126
KohjitaniA.FudaH.HanyuO.StrottC. A. (2006). Cloning, characterization and tissue expression of rat SULT2B1a and SULT2B1b steroid/sterol sulfotransferase isoforms: divergence of the rat SULT2B1 gene structure from orthologous human and mouse genes. Gene367, 66–73.10.1016/j.gene.2005.09.009
127
KostowskiW.BienkowskiP. (1999). Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol17, 63–80.10.1016/S0741-8329(98)00035-4
128
KoyamaT.HaraguchiS.VaudryH.TsutsuiK. (2009). Diurnal changes in the synthesis of 7α-hydroxypregnenolone stimulating locomotor activity in newts. Ann. N. Y. Acad. Sci.1163, 444–447.10.1111/j.1749-6632.2008.03622.x
129
KrnjevicK.SchwartzS. (1966). Is gamma-aminobutyric acid an inhibitory transmitter?Nature211, 1372–1374.10.1038/2111372a0
130
LadurelleN.EychenneB.DentonD.Blair-WestJ.SchumacherM.BaulieuE. E. (2000). Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res.858, 371–379.10.1016/S0006-8993(00)01953-3
131
LancelM.FaulhaberJ.SchiffelholzT.RomeoE.di MicheleF.HolsboerF.RupprechtR. (1997). Allopregnanolone affects sleep in a benzodiazepine-like fashion. J. Pharmacol. Exp. Ther.282, 1213–1218.
132
LandgrenS.BackstromT.DubrovskyB. (1987). The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat’s cerebral cortex. Acta Physiol. Scand.131, 33–42.10.1111/j.1748-1716.1987.tb08202.x
133
LanthierA.PatwardhanV. V. (1986). Sex steroids and 5-en-3β-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem.25, 445–449.10.1016/0022-4731(86)90259-1
134
LapchakP. A.AraujoD. M. (2001). Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. Int. Rev. Neurobiol.46, 379–397.10.1016/S0074-7742(01)46069-7
135
LapchakP. A.ChapmanD. F.NunezS. Y.ZivinJ. A. (2000). Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model. Stroke31, 1953–1957.10.1161/01.STR.31.12.3034
136
LarcherA.DelarueC.Homo-DelarcheF.KikuyamaS.KupryszewskiG.VaudryH. (1992). Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland. Endocrinology130, 475–483.10.1210/en.130.1.475
137
LarcherA.DelarueC.IdresS.LefebvreH.FeuilloleyM.VandesandeF.PelletierG.VaudryH. (1989). Identification of VT-like immunoreactivity in chromaffin cells of the frog adrenal gland: effect of VT on corticosteroid secretion. Endocrinology125, 2691–2700.10.1210/endo-125-5-2691
138
LaurineE.LafitteD.GrégoireC.SéréeE.LoretE.DouillardS.MichelB.BriandC.VerdierJ. M. (2003). Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J. Biol. Chem.278, 29979–29986.10.1074/jbc.M306767200
139
Le FollF.LouisetE.CastelH.VaudryH.CazinL. (1997a). Electrophysiological effects of various neuroactive steroids on the GABAA receptor in pituitary melanotrope cells. Eur. J. Pharmacol.331, 303–311.10.1016/S0014-2999(97)01042-X
140
Le FollF.CastelH.LouisetE.VaudryH.CazinL. (1997b). Multiple modulatory effects of the neuroactive steroid pregnanolone on GABAA receptor in frog pituitary melanotrophs. J. Physiol.504, 387–400.10.1111/j.1469-7793.1997.387be.x
141
LeskiewiczM.BudziszewskaB.Basta-KaimA.ZajacA.KacinskiM.LasonW. (2006). Effects of neurosteroids on neuronal survival: molecular basis and clinical perspectives. Acta Neurobiol. Exp. (Wars.)66, 359–367.
142
LesouhaitierO.FeuilloleyM.LihrmannI.UgoI.FasoloA.TononM. C.VaudryH. (1996). Localization of diazepam-binding inhibitor-related peptides and peripheral type benzodiazepine receptors in the frog adrenal gland. Cell Tissue Res.283, 403–412.10.1007/s004410050551
143
LesouhaitierO.FeuilloleyM.VaudryH. (1998). Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland. J. Mol. Endocrinol.20, 45–53.10.1677/jme.0.0200045
144
LihrmannI.PlaqueventJ. C.TostivintH.RaijmakersR.TononM. C.ConlonJ. M.VaudryH. (1994). Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc. Natl. Acad. Sci. U.S.A.91, 6899–6903.10.1073/pnas.91.15.6899
145
LockhartE. M.WarnerD. S.PearlsteinR. D.PenningD. H.MehrabaniS.BoustanyR. M. (2002). Allopregnanolone attenuates N-methyl-D-aspartate-induced excitotoxicity and apoptosis in human NT2 cell line in culture. Neurosci. Lett.328, 33–36.10.1016/S0304-3940(02)00448-2
146
MacKenzieE. M.OdontiadisJ.Le MelledoJ. M.PriorT. I.BakerG. B. (2007). The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell. Mol. Neurobiol.27, 541–574.10.1007/s10571-006-9086-0
147
MagnaghiV.CavarrettaI.GalbiatiM.MartiniL.MelcangiR. C. (2001). Neuroactive steroids and peripheral myelin proteins. Brain Res. Rev.37, 360–371.10.1016/S0165-0173(01)00140-0
148
MajewskaM. D. (1992). Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol.38, 379–395.10.1016/0301-0082(92)90025-A
149
MajewskaM. D.HarrisonN. L.SchwartzR. D.BarkerJ. L.PaulS. M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science232, 1004–1007.10.1126/science.2422758
150
MajewskaM. D.SchwartzR. D. (1987). Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?Brain Res.404, 355–360.10.1016/0006-8993(87)91394-1
151
MakP.BroussardC.VacyK.BroadbearJ. H. (2011). Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J. Psychopharmacol. (in press).
152
MalagonM.VaudryH.VallarinoM.Gracia-NavarroF.TononM. C. (1992a). Distribution and characterization of endozepine-like immunoreactivity in the central nervous system of the frog Rana ridibunda. Peptides13, 99–107.10.1016/0196-9781(92)90146-T
153
MalagonM.VallarinoM.TononM. C.VaudryH. (1992b). Localization and characterization of diazepam-binding inhibitor (DBI)-like peptides in the brain and pituitary of the trout (Salmo gairdneri). Brain Res.576, 208–214.10.1016/0006-8993(92)90682-Y
154
MalagonM.VaudryH.Van StrienF.PelletierG.Gracia-NavarroF.TononM. C. (1993). Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain. Neuroscience57, 777–786.10.1016/0306-4522(93)90023-9
155
MalikA. S.NarayanR. K.WendlingW. W. (2003). A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model. J. Neurotrauma20, 463–476.10.1089/089771503765355531
156
MameliM.CartaM.PartridgeL. D.ValenzuelaC. F. (2005). Neurosteroid-induced plasticity of immature synapses via retrograde modulation of presynaptic NMDA receptors. J. Neurosci.25, 2285–2294.10.1523/JNEUROSCI.2434-05.2005
157
ManjiH. K.QuirozJ. A.SpornJ.PayneJ. L.DenicoffK.GrayM. (2003). Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry53, 707–742.10.1016/S0006-3223(03)00117-3
158
MarumotoN.MurakamiN.KatayamaT.KurodaH.MurakamiT. (1996). Effects of daily injections of melatonin on locomotor activity rhythms in rats maintained under constant bright or dim light. Physiol. Behav.60, 767–773.10.1016/S0031-9384(96)00100-X
159
MatsudaK.TanakaS.YamamotoK.KikuyamaS. (1990). Annual changes of plasma prolactin levels in the newt, Cynops pyrrhogaster. Zool. Sci.7, 1143.
160
MatsudaK.WadaK.MiuraT.MaruyamaK.ShimakuraS. I.UchiyamaM.LeprinceJ.TononM. C.VaudryH. (2007). Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish. Neuroscience150, 425–432.10.1016/j.neuroscience.2007.09.012
161
MatsunagaM.UkenaK.BaulieuE. E.TsutsuiK. (2004). 7α-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proc. Natl. Acad. Sci. U.S.A.101, 17282–17287.10.1073/pnas.0407176101
162
MauriceT.GrégoireC.EspallerguesJ. (2006). Neuro(active)steroids actions at the neuromodulatory sigma1 (σ1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol. Biochem. Behav.84, 581–597.10.1016/j.pbb.2006.07.009
163
MayoW.DelluF.RobelP.CherkaouiJ.Le MoalM.BaulieuE. E.SimonH. (1993). Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res.607, 324–328.10.1016/0006-8993(93)91524-V
164
McDonaldA. J.MascagniF. (1996). Immunohistochemical localization of the β2 and β3 subunits of the GABAA receptor in the basolateral amygdala of the rat and monkey. Neuroscience75, 407–419.10.1016/0306-4522(96)00269-2
165
McEwenB. S. (1994). Steroid hormone actions on the brain: when is the genome involved?Horm. Behav.28, 396–405.10.1006/hbeh.1994.1036
166
MelcangiR. C.AzcoitiaI.BallabioM.CavarrettaI.GonzalezL. C.LeonelliE.MagnaghiV.VeigaS.Garcia-SeguraL. M. (2003). Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves. Prog. Neurobiol.71, 57–66.10.1016/j.pneurobio.2003.10.001
167
MeldrumB. (1982). Pharmacology of GABA. Clin. Neuropharmacol.5, 293–316.10.1097/00002826-198205030-00004
168
MellonS.VaudryH. (2001). Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol.46, 33–78.10.1016/S0074-7742(01)46058-2
169
MellonS. H.GriffinL. D. (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab.13, 35–43.10.1016/S1043-2760(01)00503-3
170
Mensah-NyaganA. G.Do RegoJ. L.BeaujeanD.Luu-TheV.PelletierG.VaudryH. (1999). Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev.51, 63–81.
171
Mensah-NyaganA. G.FeuilloleyM.Do RegoJ. L.MarcualA.LangeC.TononM. C.PelletierG.VaudryH. (1996). Localization of 17β-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U.S.A.93, 1423–1428.10.1073/pnas.93.4.1423
172
Mensah-NyaganA. G.FeuilloleyM.DupontE.Do RegoJ. L.LeboulengerF.PelletierG.VaudryH. (1994). Immunocytochemical localization and biological activity of 3β-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci.14, 7306–7318.
173
Meyer-LindenbergA.DomesG.KirschP.HeinrichsM. (2011). Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci.12, 524–538.10.1038/nrn3044
174
MiguesP. V.JohnstonA. N.RoseS. P. (2002). Dehydroepiandrosterone and its sulphate enhance memory retention in day-old chicks. Neuroscience109, 243–251.10.1016/S0306-4522(01)00471-7
175
MitchellE. A.GentetL. J.DempsterJ.BelelliD. (2007). GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids. J. Physiol.583, 1021–1040.10.1113/jphysiol.2007.134445
176
MoQ.LuS. F.HuS.SimonN. G. (2004). DHEA and DHEA sulfate differentially regulate neural androgen receptor and its transcriptional activity. Brain Res. Mol. Brain Res.126, 165–172.10.1016/j.molbrainres.2004.05.001
177
MocchettiI.EinsteinR.BrosiusJ. (1986). Putative diazepam binding inhibitor peptide: cDNA clones from rat. Proc. Natl. Acad. Sci. U.S.A.83, 7221–7225.10.1073/pnas.83.19.7221
178
MonnetF. P.MaheV.RobelP.BaulieuE. E. (1995). Neurosteroids, via σ receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U.S.A.92, 3774–3778.10.1073/pnas.92.9.3774
179
MonnetF. P.MauriceT. (2006). The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J. Pharmacol. Sci.100, 93–118.10.1254/jphs.CR0050032
180
MooreF. L.BoydS. K.KelleyD. B. (2005). Historical perspective: hormonal regulation of behaviors in amphibians. Horm. Behav.48, 373–383.10.1016/j.yhbeh.2005.05.011
181
MorrowA. L. (2007). Recent developments in the significance and therapeutic relevance of neuroactive steroids – introduction to the special issue. Pharmacol. Ther.116, 1–6.10.1016/j.pharmthera.2007.04.003
182
MosconiG.YamamotoK.KikuyamaS.CarnevaliO.MancusoA.VellanoC. (1994). Seasonal changes of plasma prolactin concentration in the reproduction of the crested newt (Triturus carnifex Laur). Gen. Comp. Endocrinol.95, 342–349.10.1006/gcen.1994.1132
183
MurakamiK.FellousA.BaulieuE. E.RobelP. (2000). Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly. Proc. Natl. Acad. Sci. U.S.A.97, 3579–3584.10.1073/pnas.97.7.3579
184
MurakamiN.KawanoT.NakaharaK.NasuT.ShiotaK. (2001). Effect of melatonin on circadian rhythm, locomotor activity and body temperature in the intact house sparrow, Japanese quail and owl. Brain Res.889, 220–224.10.1016/S0006-8993(00)03205-4
185
NasmanB.OlssonT.BackstromT.ErikssonS.GrankvistK.VitanenM.BuchtG. (1991). Serum dehydroepiandrosterone sulfate in Alzeimer’s disease and in multi-infarct dementia. Biol. Psychiatry30, 684–690.10.1016/0006-3223(91)90013-C
186
NguyenA. D.HerzogH.SainsburyA. (2011). Neuropeptide Y and peptide YY. Important regulators of energy metabolism. Curr. Opin. Endocrinol. Diabetes Obes.18, 56–60.10.1097/MED.0b013e3283422f0a
187
PapadopoulosV. (1993). Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev.14, 222–240.10.1210/edrv-14-2-222
188
PapadopoulosV.BaraldiM.GuilarteT. R.KnudsenT. B.LacapèreJ. J.LindemannP.NorenbergM. D.NuttD.WeizmanA.ZhangM. R.GavishM. (2006). Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci.27, 402–409.10.1016/j.tips.2006.06.005
189
PapadopoulosV.BerkovichA.KruegerK. E. (1991a). The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: regulation of steroid biosynthesis. Neuropharmacology30, 1417–1423.10.1016/S0028-3908(11)80011-0
190
PapadopoulosV.BerkovichA.KruegerK. E.CostaE.GuidottiA. (1991b). Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology129, 1481–1488.10.1210/endo-129-3-1481
191
PapadopoulosV.GuarneriP.KruegerK. E.GuidottiA.CostaE. (1992). Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. U.S.A.89, 5113–5117.10.1073/pnas.89.11.5113
192
PapadopoulosV.MukhinA. G.CostaE.KruegerK. E. (1990). The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem.265, 3772–3779.
193
ParedesR. G.AgmoA. (1992). GABA and behavior: the role of receptor subtypes. Neurosci. Biobehav. Rev.16, 145–170.10.1016/S0149-7634(05)80177-0
194
Park-ChungM.MalayevA.PurdyR. H.GibbsT. T.FarbD. H. (1999). Sulfated and unsulfated steroids modulate gamma-aminobutyric acid A receptor function through distinct sites. Brain Res.830, 72–87.10.1016/S0006-8993(99)01381-5
195
PatchevV. K.HassanA. H. S.HolsboerF.AlmeidaO. F. X. (1996). The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology15, 533–540.10.1016/S0893-133X(96)00096-6
196
PaulS. M.PurdyS. H. (1992). Neuroactive steroids. FASEB J.6, 2311–2322.
197
PhamJ.PorterJ.SvecD.EiswirthC.SvecF. (2000). The effect of dehydroepiandrosterone on Zucker rats selected for fat food preference. Physiol. Behav.70, 431–441.10.1016/S0031-9384(00)00286-9
198
PinnaG.Agis-BalboaR. C.PibiriF.NelsonM.GuidottiA.CostaE. (2008). Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem. Res.33, 1990–2007.10.1007/s11064-008-9718-5
199
Plassart-SchiessE.BaulieuE. E. (2001). Neurosteroids: recent findings. Brain Res. Rev.37, 133–140.10.1016/S0165-0173(01)00113-8
200
Polzonetti-MagniA.CarnevaliO.YamamotoK.KikuyamaS. (1995). Growth hormone and prolactin in amphibian reproduction. Zool. Sci.12, 683–694.10.2108/zsj.12.683
201
RamosE. J.MeguidM. M.CamposA. C.CoelhoJ. C. (2005). Neuropeptide Y, α-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition21, 269–279.10.1016/j.nut.2004.06.021
202
ReddyD. S. (2003). Pharmacology of endogenous neuroactive steroids. Crit. Rev. Neurobiol.15, 197–234.10.1615/CritRevNeurobiol.v15.i34.20
203
ReddyD. S. (2010). Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res.186, 113–137.10.1016/B978-0-444-53630-3.00008-7
204
ReddyD. S.KulkarniS. K. (1998). The role of the GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berl.)137, 391–400.10.1007/s002130050635
205
ReddyD. S.KulkarniS. K. (1999). Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats. Pharmacol. Biochem. Behav.62, 53–60.10.1016/S0091-3057(98)00126-9
206
ReghunandananV.ReghunandananR.MahajanK. K. (1998). Arginine vasopressin as a neurotransmitter in brain. Indian J. Exp. Biol.36, 635–643.
207
Remage-HealeyL.MaidmentN. T.SchlingerB. A. (2008). Forebrain steroid levels fluctuate rapidly during social interactions. Nat. Neurosci.11, 1327–1334.10.1038/nn.2200
208
RichardsJ. G.MöhlerH. (1984). Benzodiazepine receptors. Neuropharmacology23, 233–242.10.1016/0028-3908(84)90064-9
209
RobelP.BaulieuE. E. (1985). Neurosteroids, 3β-hydroxy-Δ5-derivatives in the rodent brain. Neurochem. Int.7, 953–958.10.1016/0197-0186(85)90143-3
210
RobelP.BaulieuE. E. (1994). Neurosteroids: biosynthesis and function. Trends Endocrinol. Metab.5, 1–8.10.1016/1043-2760(94)90114-7
211
RobelP.SchumacherM.BaulieuE. E. (1999). “Neurosteroids: from definition and biochemistry to physiopathologic function,” in Contemporary Endocrinology, eds BaulieuE. E.RobelP.SchumacherM. (Totowa: Humana Press), 1–26.
212
RobelP.YoungJ.CorpéchotC.MayoW.PercheF.HaugM.SimonH.BaulieuE. E. (1995). Biosynthesis and assay of neurosteroids in rats and mice: functional correlates. J. Steroid Biochem. Mol. Biol.53, 355–360.10.1016/0960-0760(95)00074-A
213
RobertsE. (1986). “Guides through the labyrinth of AD: dehydroepiandrosterone, potassium channels and the C4 component of complement,” in Treatment Development Strategies for Alzheimer’s Disease eds CrookT.BartusR. T.FerrisS.GershonS. (Madison, CT: Prowley), 173–219.
214
RoseT. M.SchultzE. R.TodaroG. J. (1992). Molecular cloning of the gene for the yeast homolog (ACB) of diazepam binding inhibitor/endozepine/acyl-CoA-binding protein. Proc. Natl. Acad. Sci. U.S.A.89, 11287–11291.10.1073/pnas.89.20.9662
215
RupprechtR. (1997). The neuropsychopharmacological potential of neuroactive steroids. J. Psychiatr. Res.31, 297–314.10.1016/S0022-3956(96)00060-X
216
RupprechtR.di MicheleF.HermannB.StröhleA.LancelM.RomeoE.HolsboerF. (2001). Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Rev.37, 59–67.10.1016/S0165-0173(01)00123-0
217
RupprechtR.HolsboerF. (1999). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci.22, 410–416.10.1016/S0166-2236(99)01399-5
218
RupprechtR.HolsboerF. (2001). Neuroactive steroids in neuropsychopharmacology. Int. Rev. Neurobiol.46, 461–477.10.1016/S0074-7742(01)46072-7
219
SakaueM.SaitoN.TaniguchiH.BabaS.TanakaC. (1988). Immunohistochemical localization of γ-aminobutyric acid in the rat pituitary gland and related hypothalamic regions. Brain Res.446, 343–353.10.1016/0006-8993(88)90893-1
220
SayeedI.GuoQ.HoffmanS. W.SteinD. G. (2006). Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann. Emerg. Med.47, 381–389.10.1016/j.annemergmed.2005.12.011
221
SchiessA. R.PartridgeL. D. (2005). Pregnenolone sulfate acts through a G-protein-coupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons. Eur. J. Pharmacol.25, 22–29.10.1016/j.ejphar.2005.06.007
222
SchlingerB. A.Remage-HealeyL. (2011). Neurosteroidogenesis: insights from studies of songbirds. J. Neuroendocrinol.24, 16–21.10.1111/j.1365-2826.2011.02150.x
223
SchumacherM.AkwaY.GuennounR.RobertF.LabombardaF.DesarnaudF.RobelP.De NicolaA. F.BaulieuE. E. (2000). Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol.29, 307–326.10.1023/A:1007152904926
224
SchumacherM.Weill-EngererS.LiereP.RobertF.FranklinR. J.Garcia-SeguraL. M.LambertJ. J.MayoW.MelcangiR. C.ParduczA.SuterU.CarelliC.BaulieuE. E.AkwaY. (2003). Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol.71, 3–29.10.1016/j.pneurobio.2003.09.004
225
ShannonE. E.PurdyR. H.GrantK. A. (2005a). Discriminative stimulus effects of 5.6 mg/kg pregnanolone in DBA/2J and C57BL/6J inbred mice. Alcohol37, 35–45.10.1016/j.alcohol.2005.11.001
226
ShannonE. E.PorcuP.PurdyR. H.GrantK. A. (2005b). Characterization of the discriminative stimulus effects of the neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice. J. Pharmacol. Exp. Ther.314, 675–685.10.1124/jpet.104.082644
227
ShimadaM.YoshinariK.TanabeE.ShimakawaE.KobashiM.NagataK.YamazoeY. (2001). Identification of ST2A1 as a rat brain neurosteroid sulfotransferase mRNA. Brain Res.920, 222–225.10.1016/S0006-8993(01)03061-X
228
ShimizuC.FudaH.YanaiH.StrottC. A. (2003). Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1. Endocrinology144, 1186–1193.10.1210/en.2002-221011
229
SlobodyanskyE.GuidottiA.WambebeC.BerkovichA.CostaE. (1989). Isolation and characterization of a triakontatetraneuropeptide (TTN) a posttranslational product of diazepam binding inhibitor: specific action at the Ro5-4864 recognition sites. J. Neurochem.53, 1276–1284.10.1111/j.1471-4159.1989.tb07425.x
230
SlobodyanskyE.KurrigerG.Kultas-LlinskyK. (1992). Diazepam binding inhibitor processing in the rhesus monkey brain: an immunocytochemical study. J. Chem. Neuroanat.5, 169–180.10.1016/0891-0618(92)90042-O
231
SteffensenS. C.JonesM. D.HalesK.AllisonD. W. (2006). Dehydroepiandrosterone sulfate and estrone sulfate reduce GABA-recurrent inhibition in the hippocampus via muscarinic acetylcholine receptors. Hippocampus16, 1080–1090.10.1002/hipo.20232
232
SteinD. G. (2001). Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?Trends Neurosci.24, 386–391.10.1016/S0166-2236(00)01821-X
233
StrottC. A. (2002). Sulfonation and molecular action. Endocr. Rev.23, 703–732.10.1210/er.2001-0040
234
StrousR. D.MaayanR.LapidusR.StryjerR.LustigM.KotlerM.WeizmanA. (2003). Value of dehydroepiandrosterone (DHEA) augmentation in the management of negative symptoms in schizophrenia. Arch. Gen. Psychiatry60, 133–141.10.1001/archpsyc.60.2.133
235
StrousR. D.MaayanR.WeizmanA. (2006). The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur. Neuropsychopharmacol.16, 155–169.10.1016/S0924-977X(06)70509-0
236
SunderlandT.MerrilC. R.HarringtonM. G.LawlorB. A.MolchanS. E.MartinezR.MurphyD. L. (1989). Reduced plasma dehydroepiandrosterone concentrations in Alzheimer’s disease. Lancet2, 570.10.1016/S0140-6736(89)90700-9
237
SvecF.PorterJ. (1996). Effect of DHEA on macronutrient selection by Zucker rats. Physiol. Behav.59, 721–727.10.1016/0031-9384(95)02150-7
238
SvecF.PorterJ. (1998a). Dehydroepiandrosterone: a nutritional supplement with actions in the central nervous system. Nutr. Neurosci.1, 9–19.
239
SvecF.PorterJ. (1998b). The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc. Soc. Exp. Biol. Med.218, 174–191.
240
SvecF.RichardsR. J.PorterJ. R. (1998). Investigating the debate: does DHEA alter food intake?Nutr. Neurosci.1, 93–101.
241
TakaseM.UkenaK.YamazakiT.KominamiS.TsutsuiK. (1999). Pregnenolone, pregnenolone sulfate, and cytochrome P450 side-chain cleavage enzyme in the amphibian brain and their seasonal changes. Endocrinology140, 1936–1944.10.1210/en.140.4.1936
242
TappazM. L.WassefM.OertelW. H.PautL.PujolJ. F. (1983). Light- and electron-microscopic immunocytochemistry of glutamic acid decarboxylase (GAD) in the basal hypothalamus: morphological evidence for neuroendocrine γ-aminobutyrate (GABA). Neuroscience9, 271–287.10.1016/0306-4522(83)90293-2
243
TasanR. O.LinS.HetzenauerA.SingewaldN.HerzogH.SperkG. (2009). Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience158, 1717–1730.10.1016/j.neuroscience.2008.11.048
244
TaskerJ. G.DiS.Malcher-LopesR. (2006). Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology147, 5549–5556.10.1210/en.2006-0981
245
ThompsonR. R.DickinsonP. S.RoseJ. D.DakinK. A.CivielloG. M.SegerdahlA.BartlettR. (2008). Pheromones enhance somatosensory processing in newt brains through a vasotocin-dependent mechanism. Proc. Biol. Sci.275, 1685–1693.10.1098/rspb.2007.1417
246
ThorsellA. (2010). Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp. Biol. Med.235, 1163–1167.10.1258/ebm.2010.009331
247
TodaroG. J.RoseT. M.ShoyabM. (1991). Human DBI (endozepine): relationship to a homologous membrane associated protein (MA-DBI). Neuropharmacology30, 1373–1380.10.1016/S0028-3908(11)80004-3
248
TongY.ToranzoD.PelletierG. (1991). Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides20, 33–40.10.1016/0143-4179(91)90037-J
249
TononM. C.DésyL.NicolasP.VaudryH.PelletierG. (1990). Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides15, 17–24.10.1016/0143-4179(90)90155-R
250
TononM. C.LeprinceJ.GandolfoP.CompèreV.PelletierG.MalagonM. M.VaudryH. (2006). “Endozepines,” in Handbook of Biologically Active Peptides, ed. KastinA. J. (New York: Elsevier), 813–819.
251
TorresJ. M.OrtegaE. (2003). DHEA, PREG and their sulfate derivatives on plasma and brain after CRH and ACTH administration. Neurochem. Res.28, 1187–1191.10.1023/A:1024276328127
252
ToyodaF.HasunumaI.YamamotoK.YamashitaM.KikuyamaS. (2005). Prolactin acts centrally to enhance newt courtship behavior. Gen. Comp. Endocrinol.141, 172–177.10.1016/j.ygcen.2004.12.015
253
ToyodaF.ItoM.TanakaS.KikuyamaS. (1993). Hormonal induction of male courtship behavior in the Japanese newt, Cynops pyrrhogaster. Horm. Behav.27, 511–522.10.1006/hbeh.1993.1037
254
TsutsuiK.HaraguchiS.MatsunagaM.KoyamaT.Do RegoJ. L.VaudryH. (2010). Identification of 7α-hydroxypregnenolone, a novel bioactive amphibian neurosteroid stimulating locomotor activity, and its physiological roles in the regulation of locomotion. Gen. Comp. Endocrinol.168, 275–279.10.1016/j.ygcen.2010.01.024
255
TsutsuiK.InoueK.MiyabaraH.SuzukiS.OguraY.TobariY. And Haraguchi, S. (2009). Discovery of a novel avian neurosteroid, 7α-hydroxypregnenolone, and its role in the regulation of the diurnal rhythm of locomotor activity in Japanese quail. Gen. Comp. Endocrinol.163, 117–122.10.1016/j.ygcen.2009.04.005
256
TsutsuiK.InoueK.MiyabaraH.SuzukiS.OguraY.HaraguchiS. (2008). 7α-Hydroxypregnenolone mediates melatonin action underlying diurnal locomotor rhythms. J. Neurosci.28, 2158–2167.10.1523/JNEUROSCI.3562-07.2008
257
TsutsuiK.MatsunagaM.MiyabaraH.UkenaK. (2006). Neurosteroid biosynthesis in the quail brain: a review. J. Exp. Zoolog. Part A Comp. Exp. Biol.305, 733–742.10.1002/jez.a.302
258
TsutsuiK.MatsunagaM.UkenaK. (2003). Review: biosynthesis and biological actions of neurosteroids in the avian brain. Avian Poultry Biol. Rev.14, 63–78.10.3184/147020603783641297
259
TsutsuiK.UkenaK.TakaseM.KohchiC.LeaR. W. (1999). Neurosteroid biosynthesis in vertebrate brains. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol.124, 121–129.10.1016/S0742-8413(99)00065-1
260
TsutsuiK.YamazakiT. (1995). Avian neurosteroids I. Pregnenolone biosynthesis in the quail brain. Brain Res.678, 1–9.10.1016/0006-8993(95)00116-8
261
UenoH.YamaguchiH.MizutaM.NakazatoM. (2008). The role of PYY in feeding regulation. Regul. Pept.145, 12–16.10.1016/j.regpep.2007.09.011
262
UzunovaV.CeciM.KohlerC.UzunovD. P.WrynnA. S. (2003). Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression. Brain Res.976, 1–8.10.1016/S0006-8993(03)02577-0
263
ValeraS.BallivetM.BertrandD. (1992). Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A.89, 9949–9953.10.1073/pnas.89.20.9949
264
ValléeM.MayoW.DarnauderyM.CorpéchotC.YoungJ.KoehlM.Le MoalM.BaulieuE. E.RobelP.SimonH. (1997). Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc. Natl. Acad. Sci. U.S.A.94, 14865–14870.10.1073/pnas.94.26.14865
265
ValléeM.MayoW.Le MoalM. (2001). Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive ageing. Brain Res. Rev.37, 301–312.10.1016/S0165-0173(01)00135-7
266
van BroekhovenF.VerkesR. J. (2003). Neurosteroids in depression: a review. Psychopharmacology (Berl.)165, 97–110.
267
VaudryH.Do RegoJ. L.BurelD.Luu-TheV.PelletierG.TsutsuiK. (2011). Neurosteroid biosynthesis in the brain of amphibians. Front. Neuroendocr. Sci.2:79.10.3389/fendo.2011.00079
268
Viglietti-PanzicaC.AsteN.BalthazartJ.PanzicaG. C. (1994). Vasotocinergic innervation of sexually dimorphic medial preoptic nucleus of the male Japanese quail: influence of testosterone. Brain Res.657, 171–184.10.1016/0006-8993(94)90965-2
269
von HorstenS.ExtonN. G.ExtonM. S.HelfritzF.NaveH.BallofJ.StalpM.PabstR. (1998). Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen. Brain Res.806, 282–286.10.1016/S0006-8993(98)00772-0
270
WarrenW. S.CassoneV. M. (1995). The pineal gland: photoreception and coupling of behavioral, metabolic, and cardiovascular circadian outputs. J. Biol. Rhythms10, 64–79.10.1177/074873049501000106
271
WeaverC. E.Jr.MarekP.Park-ChungM.TamS. W.FarbD. H. (1997). Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A.94, 10450–10454.10.1073/pnas.94.19.10450
272
WehrenbergW. B.CorderR.GaillardR. C. (1989). A physiological role for neuropeptide Y in regulating the estrogen/progesterone induced luteinizing hormone surge in ovariectomized rats. Neuroendocrinology49, 680–682.10.1159/000125188
273
Weill-EngererS.DavidJ. P.SazdovitchV.LiereP.EychenneB.PianosA.SchumacherM.DelacourteA.BaulieuE. E.AkwaY. (2002). Neurosteroid quantification in human brain regions: comparison between Alzheimer’s and nondemented patients. J. Clin. Endocrinol. Metab.87, 5138–5143.10.1210/jc.2002-020878
274
WojtalK.TrojnarM. K.CzuczwarS. J. (2006). Endogenous neuroprotective factors: neurosteroids. Pharmacol. Rep.58, 335–340.
275
WoolleyS. C.SakataJ. T.CrewsD. (2004). Evolutionary insights into the regulation of courtship behavior in male amphibians and reptiles. Physiol. Behav.83, 347–360.10.1016/j.physbeh.2004.08.021
276
WuF. S.GibbsT. T.FarbD. H. (1991). Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol.40, 333–336.
277
XilouriM.PapazafiriP. (2006). Anti-apoptotic effects of allopregnanolone on P19 neurons. Eur. J. Neurosci.23, 43–54.10.1111/j.1460-9568.2005.04548.x
278
YanagibashiK.OhnoY.NakamichiN.MatsuiT.HayashidaK.TakamuraM.YamadaK.TouS.KawamuraM. (1989). Peripheral-type benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria. J. Biochem.106, 1026–1029.
279
YanaseH.ShimizuH.YamadaK.IwanagaT. (2002). Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with brain-type fatty acid binding protein. Arch. Histol. Cytol.65, 27–36.10.1679/aohc.65.27
280
YoungL. T. (2002). Neuroprotective effects of antidepressant and mood stabilizing drugs. J. Psychiatry Neurosci.27, 8–9.
281
ZhengP. (2009). Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol.89, 134–152.10.1016/j.pneurobio.2009.07.001
282
ZwainI. H.ArroyoA.AmatoP.YenS. S. (2002). A role for hypothalamic astrocytes in dehydroepiandrosterone and estradiol regulation of gonadotropin-releasing hormone (GnRH) release by GnRH neurons. Neuroendocrinology75, 375–383.10.1159/000059434
Summary
Keywords
neurosteroids, glutamate, GABA, melatonin, prolactin, endozepines, vasopressin, neuropeptide Y
Citation
Do Rego JL, Seong JY, Burel D, Leprince J, Vaudry D, Luu-The V, Tonon M-C, Tsutsui K, Pelletier G and Vaudry H (2012) Regulation of Neurosteroid Biosynthesis by Neurotransmitters and Neuropeptides. Front. Endocrin. 3:4. doi: 10.3389/fendo.2012.00004
Received
31 October 2011
Accepted
05 January 2012
Published
24 January 2012
Volume
3 - 2012
Edited by
Olivier Kah, CNRS UMR 6026, France
Reviewed by
Gustavo M. Somoza, Instituto de Investigaciones Biotecnologicas-Instituto Tecnologico de Chascomus, Argentina; James A. Carr, Texas Tech University, USA
Copyright
© 2012 Do Rego, Seong, Burel, Leprince, Vaudry, Luu-The, Tonon, Tsutsui, Pelletier and Vaudry.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
*Correspondence: Hubert Vaudry, INSERM U982, European Institute for Peptide Research, IFRMP 23, University of Rouen, 76821 Mont-Saint-Aignan, France. e-mail: hubert.vaudry@univ-rouen.fr
This article was submitted to Frontiers in Neuroendocrine Science, a specialty of Frontiers in Endocrinology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.